/
Other
Esketamine
3
Pipeline Programs↗
7
Active Trials↗
2
Companies Involved↗
Esketamine is an early-stage landscape with 3 programs across 2 companies. 1 program is in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
Phase 1
No programs
Phase 21
Approved
No programs
Analysis
Trial Status
40
clinical trials
Completed20 · 50%
Unknown status11 · 28%
Recruiting6 · 15%
Withdrawn2 · 5%
Not yet recruiting1 · 3%
Clinical Trials
Trial Activity
40 trials
Effect of Esketamine on Conscious State in Patients With pDoC
Recruiting·—·N/A·NCT06389344·116 enrolled
Immunoinflammatory Regulation of Esketamine in Septic Patients
Recruiting·UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology·Phase 4·NCT04843982·100 enrolled
IV Ketamine Vs. in Esketamine for MDD TRD
Recruiting·—·N/A·NCT06488586·80 enrolled
Esketamine Combined With PRF of DRG for Acute/Subacute Zoster-associated Pain
Not yet recruiting·—·N/A·NCT06914206·184 enrolled
Intranasal Esketamine to Maintain the Antidepressant Response to IV Racemic Ketamine
Completed·—·N/A·NCT04856124·10 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)